| HOME | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|---|
| ||||||||||||||||||||||||||||||||
125 mg/dl Treated With Statins Versus No Lipid-Lowering Drug
a Cardiology Division, Westchester Medical Center/New York Medical College, Valhalla
b The Division of Clinical Epidemiology, University of Texas Medical School at Houston
c Neurocare Associates, Bronx, New York
Wilbert S. Aronow, Cardiology Division, New York Medical College, 23 Pebble Way, New Rochelle, NY 10804 E-mail: WSAronow{at}aol.com.
Background. We report the incidence of new atherothrombotic brain infarction (ABI) in older men and women with prior myocardial infarction and a serum low-density lipoprotein (LDL) cholesterol of 
125 mg/dl treated with statins and with no lipid-lowering drug.
Methods. The incidence of new ABI was investigated in an observational prospective study of 1410 men and women, mean age 81 ± 9 years, with prior myocardial infarction and a serum LDL cholesterol of 125 mg/dl treated with statins (679 persons or 48%) and with no lipid-lowering drug (731 persons or 52%). Follow-up was 36 ± 21 months.
Results. At follow-up, the stepwise Cox regression model showed that significant independent predictors of new ABI were age (risk ratio = 1.04 for a 1-year increase in age), cigarette smoking (risk ratio = 3.5), hypertension (risk ratio = 3.1), diabetes mellitus (risk ratio = 2.3), initial serum LDL cholesterol (risk ratio = 1.01 for each 1 mg/dl increase), initial serum high-density lipoprotein cholesterol (risk ratio = 0.97 for each 1 mg/dl increase), prior stroke (risk ratio = 2.5), and use of statins (risk ratio = 0.40). The Cochran-Armitage test showed a trend in the reduction of new ABI in persons treated with statins as the level of serum LDL cholesterol decreased ( p < .0001).
Conclusions. Use of statins caused a 60%, significant, independent reduction in new ABI in older men and women with prior myocardial infarction and a serum LDL cholesterol of 125 mg/dl.
This article has been cited by other articles:
 |
|
 |
|
  J. G. Robinson, G. Bakris, J. Torner, N. J. Stone, and R. Wallace Is it Time for a Cardiovascular Primary Prevention Trial in the Elderly? Stroke, February 1, 2007; 38(2): 441 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. S. Aronow Drug Treatment of Systolic and of Diastolic Heart Failure in Elderly Persons J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2005; 60(12): 1597 - 1605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sanal and W. S. Aronow Effect of an Educational Program on the Prevalence of Use of Antiplatelet Drugs, Beta Blockers, Angiotensin-Converting Enzyme Inhibitors, Lipid-Lowering Drugs, and Calcium Channel Blockers Prescribed During Hospitalization and at Hospital Discharge in Patients With Coronary Artery Disease J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2003; 58(11): M1046 - 1048. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Suryadevara, S. G. Storey, W. S. Aronow, and C. Ahn Association of Abnormal Serum Lipids in Elderly Persons With Atherosclerotic Vascular Disease and Dementia, Atherosclerotic Vascular Disease Without Dementia, Dementia Without Atherosclerotic Vascular Disease, and No Dementia or Atherosclerotic Vascular Disease J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2003; 58(9): M859 - 861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ghosh and W. S. Aronow Utilization of Lipid-Lowering Drugs in Elderly Persons With Increased Serum Low-Density Lipoprotein Cholesterol Associated With Coronary Artery Disease, Symptomatic Peripheral Arterial Disease, Prior Stroke, or Diabetes Mellitus Before and After an Educational Program on Dyslipidemia Treatment J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2003; 58(5): M432 - 435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Banks and J. E. Morley Memories Are Made of This: Recent Advances in Understanding Cognitive Impairments and Dementia J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2003; 58(4): M314 - 321. [Full Text] [PDF]
|
|
|
|
|
|
W. S. Aronow, C. Ahn, and H. Gutstein Reduction of New Coronary Events and New Atherothrombotic Brain Infarction in Older Persons With Diabetes Mellitus, Prior Myocardial Infarction, and Serum Low-Density Lipoprotein Cholesterol >=125 mg/dl Treated With Statins J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2002; 57(11): M747 - 750. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. S. Aronow Guest Editorial: What Is the Appropriate Treatment of Hypertension in Elders? J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2002; 57(8): M483 - 486. [Full Text] [PDF]
|
|
|
|
|
|
W. S. Aronow Guest Editorial: Should Hypercholesterolemia in Older Persons Be Treated to Reduce Cardiovascular Events? J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2002; 57(7): M411 - 413. [Full Text]
|
|
| HOME | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|---|
